{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:34:57Z","timestamp":1777044897685,"version":"3.51.4"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,9,2]],"date-time":"2004-09-02T00:00:00Z","timestamp":1094083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Intravenous immunoglobulins (IVIg) have immunomodulatory effects <jats:italic>in vivo<\/jats:italic> and are widely used in the treatment of autoimmune diseases, such as idiopathic thrombocytopenic purpura (ITP). The mechanisms by which IVIg can prevent platelet clearance in ITP patients are not fully understood but are known to require the participation of low affinity Fc<jats:italic>\u03b3<\/jats:italic> receptors (Fc<jats:italic>\u03b3<\/jats:italic>Rs), which interact poorly with monomeric immunoglobulin G (IgG). Given the importance of low affinity Fc<jats:italic>\u03b3<\/jats:italic>Rs in the treatment of ITP, we hypothesized that immune complexes (IC) produced <jats:italic>in vitro<\/jats:italic> could reproduce the effects of IVIg. Small\u2010size tetramolecular IC were prepared using mouse monoclonal anti\u2010human IgG and human Fc fragments. The effects of tetramolecular IC and IVIg on the <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> inhibition of phagocytosis of opsonized blood cells were compared. The results obtained showed that tetramolecular IC were at least six times more efficient than IVIg to prevent phagocytosis of opsonized red blood cells <jats:italic>in vitro<\/jats:italic>, and clearance of platelets in the thrombocytopenic mouse model.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05105.x","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T15:40:17Z","timestamp":1095867617000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Tetramolecular immune complexes are more efficient than IVIg to prevent antibody\u2010dependent <i>in vitro<\/i> and <i>in vivo<\/i> phagocytosis of blood cells"],"prefix":"10.1111","volume":"127","author":[{"given":"Ren\u00e9e","family":"Bazin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9al","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"St\u2010Amour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,2]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(93)90160-D"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(89)90210-X"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1990.tb01105.x"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00080-3"},{"key":"e_1_2_14_6_1","first-page":"883","article-title":"Infusion of a monoclonal anti\u2010FcR III in patients with refractory ITP","volume":"169","author":"Bussel J.B.","year":"1990","journal-title":"Neo-Adjuvant Chemotherapy"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198605083141907"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1029"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03136.x"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0023"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.203"},{"key":"e_1_2_14_12_1","first-page":"P094","article-title":"A monocytic chemiluminescent assay for red blood cell and platelet phagocytosis in the presence of IVIg","volume":"78","author":"Denomme G.A.","year":"2000","journal-title":"Vox Sanguinis"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)02014-2"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/bio.1170050406"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra993360"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0290(19990720)64:2<135::AID-BIT2>3.0.CO;2-Q"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00519.x"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2598"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830160615"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1993.tb02131.x"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(00)90111-2"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm921"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5489.84"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5503.484"},{"key":"e_1_2_14_25_1","first-page":"52","article-title":"Clinical experience with anti\u2010D in the treatment of idiopathic thrombocytopenic purpura","volume":"35","author":"Scaradavou A.","year":"1998","journal-title":"Seminars in Hematology"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.1990.12.2.131"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1994.tb00861.x"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.1095"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(88)90361-4"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05105.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05105.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05105.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:43:39Z","timestamp":1697417019000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05105.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05105.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05105.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,2]]},"assertion":[{"value":"2004-09-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}